Memory chipmaker Micron Technology Inc. (NASDAQ: MU) on Wednesday reported stronger-than-expected earnings for the first quarter of fiscal 2026. Revenue increased 57%
Pfizer Inc.
-(PFE)
XNYS:PFE
Pfizer affirms FY25 earnings guidance, provides full-year 2026 outlook
Pfizer Inc. (NYSE: PFE) has reaffirmed its earnings outlook for fiscal 2025 and revised revenue guidance. The pharma giant also initiated guidance
Key takeaways from Pfizer’s (PFE) Q3 2025 earnings report
Shares of Pfizer Inc. (NYSE: PFE) stayed green during midday trade on Tuesday following the company’s announcement of its third quarter 2025
PFE Earnings: All you need to know about Pfizer’s Q3 2025 earnings results
Pfizer Inc. (NYSE: PFE) reported its third quarter 2025 earnings results today. Revenues were $16.7 billion, down 6% on a reported basis
PFE Earnings: All you need to know about Pfizer’s Q2 2025 earnings results
Pfizer Inc. (NYSE: PFE) reported its second quarter 2025 earnings results today. Revenues were $14.7 billion, up 10% year-over-year. Reported net income
Key highlights from Pfizer’s (PFE) Q1 2025 earnings results
Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP net income
PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2024 financial results
Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2024 earnings results today. Revenues increased 22% year-over-year to $17.8 billion. GAAP net income
Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance
Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company
Key takeaways from Pfizer’s (PFE) Q3 2024 earnings report
Shares of Pfizer Inc. (NYSE: PFE) were down over 1% on Tuesday, despite the company delivering better-than-expected earnings results for the third
PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2024 financial results
Pfizer Inc. (NYSE: PFE) reported its third quarter 2024 earnings results today. Revenues increased 31% year-over-year to $17.7 billion. Revenues increased 32%
Pfizer (PFE) Q2 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today. Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3%
Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report
Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results.
Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined
Key takeaways from Pfizer’s (PFE) Q4 2023 earnings report
Shares of Pfizer Inc. (NYSE: PFE) were down 1% in midday trade on Tuesday. The stock has dropped 38% over the past
PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2023 financial results
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today. Revenues declined 41% year-over-year to $14.2 billion, missing estimates. The company
Key takeaways from Pfizer’s (PFE) Q3 2023 earnings results
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday, after the company delivered lackluster results for the third quarter of 2023.
PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2023 financial results
Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company reported a
Key takeaways from Pfizer’s (PFE) Q2 2023 earnings report
Shares of Pfizer Inc. (NYSE: PFE) were down over 1% on Tuesday after the company delivered mixed results for the second quarter
PFE Earnings: All you need to know about Pfizer’s Q2 2023 earnings results
Pfizer Inc. (NYSE: PFE) reported second quarter 2023 earnings results today. Revenues decreased 54% year-over-year to $12.7 billion. Reported net income declined
Pfizer inc (PFE) Q1 2023 Earnings Call Transcript
Pfizer inc (NYSE:PFE) Q1 2023 Earnings Call dated May. 02, 2023. Corporate Participants: Christopher Stevo -- Senior Vice President, Investor Relations Officer Dr.
Pfizer (PFE): Declines in COVID-19 products expected to drag down overall revenue in 2023
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday despite the company delivering better-than-expected results for the first quarter of 2023.